Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Co-Diagnostics (CODX) is a stock that can certainly grab the attention of many ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing. The agreement aims ...

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Discovery Inc - Series A (Symbol: DISCA), where a total of 66,153 contracts have traded so ...

CODX is a manufacturer of PCR tests. The company also holds two patents on specific PCR methods that increase the test's accuracy. Before the pandemic, the company had little revenue and enormous ...

CoDiagnostics, Inc. (CODX) closed at $18.19 in the latest trading session, marking a +1% move from the prior day. The stock lagged the S&P 500's daily gain of 1.05%. Meanwhile, the Dow gained 1.44%, ...

Co-Diagnostics (NASDAQ:CODX) shares sold off for the second straight session on Monday as H.C. Wainwright downgraded the COVID-19 test maker and halved its price target, citing lower-than-expected Q4 ...